Lymphoma in Hamsters: Transmission and Symptoms

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a hamster to develop cancer, especially lymphoma. Lymphoma in hamsters is usually the result of the Hamster Polyoma Virus.

Golden Hamsters as Pets

The most popular breed of hamster as a pet, the golden or Syrian hamster came from Syria (as one might expect) in 1839, but they did become commercially available until the mid-1940s. They are calm, easygoing, and don't mind being handled. They are one of the largest kinds of hamster.

Hamster Polyoma Virus

In the 1970s, hamster aficionados began to notice a new infectious form of lymphoma in hamsters. Initially confined to European populations, this disease, termed Hamster Polyoma Virus (HaPV) by researchers, has since appeared in North American hamsters. It is still relatively rare, and cannot be transmitted to humans or any other animals.

As a member of the Papovaviridae family of virus, HaPV is noteworthy for the vast array of secondary diseases that it can cause. In its role as a trigger for hamster lymphoma, it can produce any of a number of variations of that disease, leading to its classification as a polyoma.

Transmission and Symptoms

HaPV is likely spread by exposure to the urine of infected animals. Symptoms will appear between four and 30 weeks following exposure, and can include palpable tumors, weight loss, scaly skin (mange), and trichepitheliomas, which are wartlike nodules that appear on the skin around the eyes, mouth, and anus.

An extremely infectious virus, HaPV can spread to nearly 80 percent of a given hamster population with ease. Breeders in particular must be extremely vigilant and maintain high standards of hygiene to prevent contact with infected urine.

Diagnosis

There is no reliable test for HaPV, but lymphomas not caused by HaPV are exceedingly rare, especially among young hamsters, so often the cancer itself is indicative of HaPV. Furthermore, trichepitheliomas in hamsters are only ever caused by HaPV, making their appearance sufficient for a definitive diagnosis.

Treatment

There is currently no cure for HaPV. While proper hygiene measures may help slow the disease, only by euthanizing the entire infected population can the disease be completely halted. Individual hamster owners need not take these precautions unless another healthy hamster is present. Before placing healthy hamsters in enclosures that belonged to HaPV-positive animals, the environment should be thoroughly decontaminated with an antiviral agent like Virkon.

Photo: Pixabay

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap